← FDA Drug Approvals (Drugs@FDA)

ENDARI

NDA · New Drug Application · Sponsor: EMMAUS MEDCL · Approved 2017-07-07

Drug application

FDA Application #

NDA208587

Application type

New Drug Application

Brand name

ENDARI

Generic name

GLUTAMINE

Active ingredients

L-GLUTAMINE

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

EMMAUS MEDCL

Manufacturer

Emmaus Medical, Inc.

First approval

2017-07-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown